Interventional closure of atrial septal defects without fluoroscopy in adult and pediatric patients
Interventional closure of atrial septal defects (ASDs) with a transcatheter device is the preferred strategy in children and adults. This procedure has been proven in numerous studies, but X-ray and contrast agent exposure is still a major side effect. The aim of this study was to clarify whether the interventional closure of ASDs is possible and safe if it is guided by transesophageal echocardiography (TEE) alone.
Methods and results
We retrospectively selected and studied pediatric and adult patients with interventional closure of ASDs at the Deutsches Herzzentrum Berlin (DHZB) without fluoroscopy between 1999 and 2010. We included 330 out of 1,605 patients; 254 had an ASD II, 30 a PFO and 46 multiperforated atrial septum. Median age was 8.92 (0.96–76.3) years and median body weight 32.6 (8.3–156) kg. Median stretched defect size was 13 (5–29) mm. Median procedure time was 50 (20–170) min. Closure was performed in the majority of patients with the Amplatzer® septal occluder or Amplatzer® PFO occluder. The procedure succeeded in 98.2 % of cases and closure rate was 94.9 % after 48 h. Complication rate was low and procedure time was similar to that necessary with studies using fluoroscopy.
Interventional closure of ASDs is safe and effective if guided with TEE alone. The results can compete with those with the use of fluoroscopy. TEE-guided closure of ASD should be considered in more catheter laboratories to avoid unnecessary radiation exposure for the patient and the examiner.
KeywordsInterventional closure Atrial septal defects Without fluoroscopy Adult Pediatric patients
Amplatzer® PFO occluder
Atrial septal defect
Amplatzer® septal occluder
Persistent foramen ovale
We thank Anne M. Gale for editorial assistance and all nurses from the catheterization lab for their extraordinarily motivated work.
Conflict of interest
No authors have potential conflicts of interest to disclose.
- 5.Rossi RI, Cardoso Cde O, Machado PR, Francois LG, Horowitz ES, Sarmento-Leite R (2008) Transcatheter closure of atrial septal defect with Amplatzer device in children aged less than 10 years old: immediate and late follow-up. Catheter Cardiovasc Interv 71(2):231–236. doi: 10.1002/ccd.21361 PubMedCrossRefGoogle Scholar
- 7.Yakoumakis EN, Gialousis GI, Papadopoulou D, Makri T, Pappouli Z, Yakoumakis N, Papagiannis P, Georgiou E (2009) Estimation of children’s radiation dose from cardiac catheterisations, performed for the diagnosis or the treatment of a congenital heart disease using TLD dosimetry and Monte Carlo simulation. J Radiol Prot 29(2):251–261. doi: 10.1088/0952-4746/29/2/011 PubMedCrossRefGoogle Scholar
- 12.Li GS, Kong GM, Wang YL, Jin YP, Ji QS, Li JF, You BA, Zhang Y (2009) Safety and efficacy of transcatheter closure of atrial septal defects guided by transthoracic echocardiography: a prospective study from two Chinese Medical Centers. Ultrasound Med Biol 35(1):58–64. doi: 10.1016/j.ultrasmedbio.2008.06.008 PubMedCrossRefGoogle Scholar
- 13.Rigatelli G, Cardaioli P, Braggion G, Aggio S, Giordan M, Magro B, Nascimben A, Favaro A, Roncon L (2007) Transesophageal echocardiography and intracardiac echocardiography differently predict potential technical challenges or failures of interatrial shunts catheter-based closure. J Interv Cardiol 20(1):77–81. doi: 10.1111/j.1540-8183.2007.00219.x PubMedCrossRefGoogle Scholar
- 14.Taniguchi M, Akagi T, Watanabe N, Okamoto Y, Nakagawa K, Kijima Y, Toh N, Ohtsuki S, Kusano K, Sano S (2009) Application of real-time three-dimensional transesophageal echocardiography using a matrix array probe for transcatheter closure of atrial septal defect. J Am Soc Echocardiogr 22(10):1114–1120. doi: 10.1016/j.echo.2009.06.008 PubMedCrossRefGoogle Scholar
- 15.Chen FL, Hsiung MC, Hsieh KS, Li YC, Chou MC (2006) Real time three-dimensional transthoracic echocardiography for guiding Amplatzer septal occluder device deployment in patients with atrial septal defect. Echocardiography 23(9):763–770. doi: 10.1111/j.1540-8175.2006.00322.x PubMedCrossRefGoogle Scholar
- 16.Balzer J, van Hall S, Rassaf T, Boring YC, Franke A, Lang RM, Kelm M, Kuhl HP (2010) Feasibility, safety, and efficacy of real-time three-dimensional transoesophageal echocardiography for guiding device closure of interatrial communications: initial clinical experience and impact on radiation exposure. Eur J Echocardiogr 11(1):1–8. doi: 10.1093/ejechocard/jep116 PubMedCrossRefGoogle Scholar
- 18.Ewert P, Berger F (2010) Transcatheter ASD Closure without Flouroscopy. In: Hijazi ZM, Feldmann T, Al-Qbandi MHA, Sievert H (eds) Transcatheter closure of ASDs and PFOs: a comprhensive assessment. Cardiotext Publishing, USA, pp 257–262Google Scholar
- 21.Everett AD, Jennings J, Sibinga E, Owada C, Lim DS, Cheatham J, Holzer R, Ringewald J, Bandisode R, Ringel R (2009) Community use of the amplatzer atrial septal defect occluder: results of the multicenter MAGIC atrial septal defect study. Pediatr Cardiol 30(3):240–247. doi: 10.1007/s00246-008-9325-x PubMedCrossRefGoogle Scholar
- 26.Sun ZL, Xie QY, Yang TL, Pu XQ, Zheng ZF, Li CC, Chen XB, Deng JH, Meng SY (2008) Transthoracic echocardiography in transcatheter closure of atrial septal aneurysm combined with secoundum-type atrial septal defect. Zhong Nan Da Xue Xue Bao Yi Xue Ban 33(8):755–760. doi: 1672-7347(2008)08-0755-06 PubMedGoogle Scholar
- 30.Schubert S, Ewert P, Itam A, Prsa M, Peters B, Berger F (2010) Sedation with propofol during diagnostic and interventional heart catheterization vol 42nd. Annual meeting of the German Society of Pediatric Cardiology, AbstractsGoogle Scholar
- 31.Koruk S, Mizrak A, Kaya Ugur B, Ilhan O, Baspinar O, Oner U (2010) Propofol/dexmedetomidine and propofol/ketamine combinations for anesthesia in pediatric patients undergoing transcatheter atrial septal defect closure: a prospective randomized study. Clin Ther 32(4):701–709. doi: S0149-2918(10)00134-7 PubMedCrossRefGoogle Scholar